-
Je něco špatně v tomto záznamu ?
Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat
P. Aronsson, R. Vesela, M. Johnsson, Y. Tayem, V. Wsol, M. Winder, G. Tobin,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2013
Hindawi Publishing Open Access
od 2001-01-01
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2012-12-04
Open Access Digital Library
od 2013-01-01
CINAHL Plus with Full Text (EBSCOhost)
od 2013-01-01
Medline Complete (EBSCOhost)
od 2013-01-01
Health & Medicine (ProQuest)
od 2013
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
24982868
DOI
10.1155/2014/359179
Knihovny.cz E-zdroje
- MeSH
- adenosin farmakologie MeSH
- adenosintrifosfát farmakologie MeSH
- cyklofosfamid MeSH
- cystitida farmakoterapie patologie patofyziologie MeSH
- imunohistochemie MeSH
- inhibitory enzymů farmakologie terapeutické užití MeSH
- mastocyty účinky léků patologie MeSH
- methacholinchlorid farmakologie MeSH
- močový měchýř účinky léků patologie patofyziologie MeSH
- potkani Sprague-Dawley MeSH
- purinergní receptory metabolismus MeSH
- receptory muskarinové metabolismus MeSH
- svalová kontrakce účinky léků MeSH
- synthasa oxidu dusnatého antagonisté a inhibitory metabolismus MeSH
- techniky in vitro MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Nitric oxide (NO) has pivotal roles in cyclophosphamide- (CYP-) induced cystitis during which mucosal nitric oxide synthase (NOS) and muscarinic M5 receptor expressions are upregulated. In cystitis, urothelial muscarinic NO-linked effects hamper contractility. Therefore we wondered if a blockade of this axis also affects the induction of cystitis in the rat. Rats were pretreated with saline, the muscarinic receptor antagonist 4-DAMP (1 mg/kg ip), or the NOS inhibitor L-NAME (30 mg/kg ip) for five days. 60 h before the experiments the rats were treated with saline or CYP. Methacholine-, ATP-, and adenosine-evoked responses were smaller in preparations from CYP-treated rats than from saline-treated ones. Pretreatment with 4-DAMP did not change this relation, while pretreatment with L-NAME normalized the responses in the CYP-treated animals. The functional results were strengthened by the morphological observations; 4-DAMP pretreatment did not affect the parameters studied, namely, expression of muscarinic M5 receptors, P1A1 purinoceptors, mast cell distribution, or bladder wall enlargement. However, pretreatment with L-NAME attenuated the differences. Thus, the current study provides new insights into the complex mechanisms behind CYP-induced cystitis. The NO effects coupled to urothelial muscarinic receptors have a minor role in the development of cystitis. Inhibition of NOS may prevent the progression of cystitis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014175
- 003
- CZ-PrNML
- 005
- 20150421092128.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/359179 $2 doi
- 035 __
- $a (PubMed)24982868
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Aronsson, Patrik $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden. $7 gn_A_00008807
- 245 10
- $a Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat / $c P. Aronsson, R. Vesela, M. Johnsson, Y. Tayem, V. Wsol, M. Winder, G. Tobin,
- 520 9_
- $a Nitric oxide (NO) has pivotal roles in cyclophosphamide- (CYP-) induced cystitis during which mucosal nitric oxide synthase (NOS) and muscarinic M5 receptor expressions are upregulated. In cystitis, urothelial muscarinic NO-linked effects hamper contractility. Therefore we wondered if a blockade of this axis also affects the induction of cystitis in the rat. Rats were pretreated with saline, the muscarinic receptor antagonist 4-DAMP (1 mg/kg ip), or the NOS inhibitor L-NAME (30 mg/kg ip) for five days. 60 h before the experiments the rats were treated with saline or CYP. Methacholine-, ATP-, and adenosine-evoked responses were smaller in preparations from CYP-treated rats than from saline-treated ones. Pretreatment with 4-DAMP did not change this relation, while pretreatment with L-NAME normalized the responses in the CYP-treated animals. The functional results were strengthened by the morphological observations; 4-DAMP pretreatment did not affect the parameters studied, namely, expression of muscarinic M5 receptors, P1A1 purinoceptors, mast cell distribution, or bladder wall enlargement. However, pretreatment with L-NAME attenuated the differences. Thus, the current study provides new insights into the complex mechanisms behind CYP-induced cystitis. The NO effects coupled to urothelial muscarinic receptors have a minor role in the development of cystitis. Inhibition of NOS may prevent the progression of cystitis.
- 650 _2
- $a adenosin $x farmakologie $7 D000241
- 650 _2
- $a adenosintrifosfát $x farmakologie $7 D000255
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cyklofosfamid $7 D003520
- 650 _2
- $a cystitida $x farmakoterapie $x patologie $x patofyziologie $7 D003556
- 650 _2
- $a inhibitory enzymů $x farmakologie $x terapeutické užití $7 D004791
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mastocyty $x účinky léků $x patologie $7 D008407
- 650 _2
- $a methacholinchlorid $x farmakologie $7 D016210
- 650 _2
- $a svalová kontrakce $x účinky léků $7 D009119
- 650 _2
- $a synthasa oxidu dusnatého $x antagonisté a inhibitory $x metabolismus $7 D019001
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a receptory muskarinové $x metabolismus $7 D011976
- 650 _2
- $a purinergní receptory $x metabolismus $7 D011983
- 650 _2
- $a močový měchýř $x účinky léků $x patologie $x patofyziologie $7 D001743
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vesela, Renata $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden ; Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic.
- 700 1_
- $a Johnsson, Martin $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden.
- 700 1_
- $a Tayem, Yasin $u Department of Physiology and Pharmacology, Faculty of Medicine, Al-Quds University, P.O. Box 51000, Jerusalem, West Bank, Palestine.
- 700 1_
- $a Wsol, Vladimir $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic.
- 700 1_
- $a Winder, Michael $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden.
- 700 1_
- $a Tobin, Gunnar $u Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, P.O. Box 431, 40530 Gothenburg, Sweden.
- 773 0_
- $w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2014, č. - (2014), s. 359179
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24982868 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150421092426 $b ABA008
- 999 __
- $a ok $b bmc $g 1071756 $s 897053
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 359179 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
- LZP __
- $a Pubmed-20150420